{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:52:54Z","timestamp":1793987574679,"version":"4.8.0"},"reference-count":41,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background: Common variable immunodeficiency (CVID) is a complex, predominantly antibody deficiency usually diagnosed between 20\u201340 years. Few data about elderly patients are reported in the literature. Our aim was to evaluate the clinical phenotypes of elderly patients with CVID. Method: A retrospective analysis of adult patients with CVID was performed in our Referral Centre, focusing on the main differences between \u201colder\u201d patients (\u226565 years at the diagnosis) and \u201cyounger\u201d patients (&lt;65 years). Results: The data from 65 younger and 13 older patients followed up for a median period of 8.5 years were available. At diagnosis, recurrent infections represented the only clinical manifestation in 61% and 69% of younger and older patients, respectively. The incidence of autoimmune diseases was higher in elderly patients compared with younger ones (30 vs. 18%, respectively). During the follow-up, the incidence of autoimmune disorders and enteropathy increased in the younger patients whereas neoplasia became the most prevalent complication in the elderly (38%). All patients received a replacement therapy with immunoglobulin, with good compliance. Conclusion: CVID occurrence in elderly patients is rarely described; therefore, the clinical characteristics are not completely known. In our series, neoplasia became the most prevalent complication in the elderly during the follow-up. In elderly patients, 20% SCIg was as safe as in the younger ones, with good compliance. A genetic analysis is important to confirm the diagnosis, identify specific presentations in the different ages, clarify the prognosis and guide the treatment. Future clinical research in this field may potentially help to guide their care.<\/jats:p>","DOI":"10.3390\/biomedicines10030635","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T11:30:38Z","timestamp":1646825438000},"page":"635","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9608-2252","authenticated-orcid":false,"given":"Maria Giovanna","family":"Danieli","sequence":"first","affiliation":[{"name":"Department of Clinical and Molecular Sciences, Marche Polytechnic University, 60126 Ancona, Italy"},{"name":"Department of Internal Medicine, Clinica Medica, Ospedali Riuniti, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mezzanotte","sequence":"additional","affiliation":[{"name":"Internal Medicine Residency Program, Marche Polytechnic University, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3814-5937","authenticated-orcid":false,"given":"Jacopo Umberto","family":"Verga","sequence":"additional","affiliation":[{"name":"Department of Life and Environmental Sciences, Marche Polytechnic University, 60131 Ancona, Italy"},{"name":"The SFI Centre for Research Training in Genomics Data Science, National University of Ireland, H91 FYH2 Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Menghini","sequence":"additional","affiliation":[{"name":"Section of Internal Medicine, Ospedale di Civitanova Marche, 62012 Civitanova Marche, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Pedini","sequence":"additional","affiliation":[{"name":"Section of Internal Medicine, Department of Medicine, Carlo Poma Hospital, 46100 Mantova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Beatrice","family":"Bil\u00f2","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Sciences, Marche Polytechnic University, 60126 Ancona, Italy"},{"name":"Allergy Unit, Department of Internal Medicine, Ospedali Riuniti, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Moroncini","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Sciences, Marche Polytechnic University, 60126 Ancona, Italy"},{"name":"Department of Internal Medicine, Clinica Medica, Ospedali Riuniti, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International Consensus Document (ICON): Common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13023-018-0941-0","article-title":"Plasma Protein Therapeutics Association (PPTA) Taskforce. The burden of common variable immunodeficiency disorders: A retrospective analysis of the European Society for Immunodeficiency (ESID) registry data","volume":"13","author":"Odnoletkova","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaip.2013.09.015","article-title":"The variable in common variable immunodeficiency: A disease of complex phenotypes","volume":"1","author":"Jolles","year":"2013","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3389\/fimmu.2018.00694","article-title":"Delayed Diagnosis and Complications of Predominantly Antibody Deficiencies in a Cohort of Australian Adults","volume":"9","author":"Slade","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40266-013-0079-7","article-title":"Therapeutic management of primary immunodeficiency in older patients","volume":"30","author":"Verma","year":"2013","journal-title":"Drugs Aging"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/1744666X.2018.1481750","article-title":"Keeping it in the family: The case for considering late-onset combined immunodeficiency a subset of common variable immunodeficiency disorders","volume":"14","author":"Ameratunga","year":"2018","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_8","unstructured":"European Society for Immunodeficiencies (ESID) Documenting Centers (2022, March 07). Registry Working Party Documenting Centers. Available online: https:\/\/www.esid.org\/Working-Parties\/Registry-Working-Party\/Documenting-centers."},{"key":"ref_9","unstructured":"ESID Registry-Working Definitions for Clinical Diagnosis of PID (2022, March 07). ESID 2019 Revised Registry Criteria. Available online: https:\/\/www.esid.org\/content\/download\/17141\/463543\/file\/ESID%20Clin%20Crit_omim_orpha_hpo_11_2019fin.pdf."},{"key":"ref_10","unstructured":"Clinical Working Party Diagnostic Criteria for PID (2022, March 07). Differential Diagnosis of Hypogammaglobulinemia. Available online: https:\/\/www.esid.org\/Working-Parties\/Clinical-Working-Party\/Resources\/Diagnostic-criteria-for-PID2#Q5."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04384.x","article-title":"Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme","volume":"165","author":"Dhalla","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.3389\/fimmu.2018.02546","article-title":"Gastric Cancer Is the Leading Cause of Death in Italian Adult Patients With Common Variable Immunodeficiency","volume":"9","author":"Pulvirenti","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: Defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: Division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","article-title":"Italian Primary Immunodeficiency Network. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency","volume":"27","author":"Quinti","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/cei.12105","article-title":"The German national registry for primary immunodeficiencies (PID)","volume":"173","author":"Gathmann","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13223-020-00451-z","article-title":"Incidence of malignancy in patients with common variable immunodeficiency according to therapeutic delay: An Italian retrospective, monocentric cohort study","volume":"16","author":"Pedini","year":"2020","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s10875-017-0415-5","article-title":"Two Sides of the Same Coin: Pediatric-Onset and Adult-Onset Common Variable Immune Deficiency","volume":"37","author":"Sanchez","year":"2017","journal-title":"J. Clin. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/17476348.2019.1641085","article-title":"Appropriate lung management in patients with primary antibody deficiencies","volume":"13","author":"Cinetto","year":"2019","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fimmu.2020.00149","article-title":"Non-infectious Complications of Common Variable Immunodeficiency: Updated Clinical Spectrum, Sequelae, and Insights to Pathogenesis","volume":"11","author":"Ho","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/cei.13272","article-title":"British Society for Immunology\/United Kingdom Primary Immunodeficiency Network consensus statement on managing non-infectious complications of common variable immunodeficiency disorders","volume":"196","author":"Bethune","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"ref_22","unstructured":"Regional Health Agency (2022, March 07). Marche Region Health Report. Available online: http:\/\/www.regione.marche.it\/ars\/Osservatorio-Epidemiologico\/Profilo-di-salute."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/1744666X.2019.1658523","article-title":"Malignancy in common variable immunodeficiency: A systematic review and meta-analysis","volume":"15","author":"Kiaee","year":"2019","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jaci.2019.01.051","article-title":"Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies","volume":"144","author":"Milito","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2165\/11592740-000000000-00000","article-title":"Special considerations with the use of intravenous immunoglobulin in older persons","volume":"28","author":"Cheng","year":"2011","journal-title":"Drugs Aging"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s10875-016-0327-9","article-title":"Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20% in Patients with Primary Immunodeficiency Diseases in North America","volume":"36","author":"Suez","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"805705","DOI":"10.3389\/fimmu.2021.805705","article-title":"Replacement and immunomodulatory activities of 20% subcutaneous immunoglobulin treatment: A single-center retrospective study in autoimmune myositis and CVID patients","volume":"12","author":"Danieli","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.gendis.2019.10.002","article-title":"Recent advances in elucidating the genetics of common variable immunodeficiency","volume":"7","author":"Aggarwal","year":"2019","journal-title":"Genes Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J. Clin. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"753978","DOI":"10.3389\/fimmu.2021.753978","article-title":"Monogenic Adult-Onset Inborn Errors of Immunity","volume":"12","author":"Staels","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41423-020-00520-8","article-title":"Beyond monogenetic rare variants: Tackling the low rate of genetic diagnoses in predominantly antibody deficiency","volume":"18","author":"Edwards","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Khandia, R., Alqahtani, T., and Alqahtani, A.M. (2021). Genes Common in Primary Immunodeficiencies and Cancer Display Overrepresentation of Codon CTG and Dominant Role of Selection Pressure in Shaping Codon Usage. Biomedicines, 9.","DOI":"10.3390\/biomedicines9081001"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1016\/j.bbagen.2016.06.014","article-title":"Understanding the genetic and epigenetic basis of common variable immunodeficiency disorder through omics approaches","volume":"1860","author":"Li","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subj."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/cei.12947","article-title":"The role of genomics in common variable immunodeficiency disorders","volume":"188","author":"Kienzler","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12016-017-8645-0","article-title":"Review: Diagnosing Common Variable Immunodeficiency Disorder in the Era of Genome Sequencing","volume":"54","author":"Ameratunga","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/606059","article-title":"Late-onset combined immune deficiency: A subset of common variable immunodeficiency with severe T cell defect","volume":"49","author":"Malphettes","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10875-018-0574-z","article-title":"Autoimmunity and inflammation in CVID: A possible crosstalk between immune activation, gut microbiota, and epigenetic modifications","volume":"39","author":"Fevang","year":"2019","journal-title":"J. Clin. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41586-019-1411-0","article-title":"Advances in epigenetics link genetics to the environment and disease","volume":"571","author":"Cavalli","year":"2019","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00005-016-0414-x","article-title":"Indications to epigenetic dysfunction in the pathogenesis of common variable immunodeficiency","volume":"65","author":"Rae","year":"2017","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1038\/emboj.2011.124","article-title":"Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53","volume":"30","author":"Ugalde","year":"2011","journal-title":"EMBO J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"481","DOI":"10.26502\/acmcr.96550124","article-title":"A case of CVID-associated inflammatory bowel disease with CTLA-4 mutation treated with abatacept","volume":"3","author":"Danieli","year":"2019","journal-title":"Arch. Clin. Med. Case. Rep."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/3\/635\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:33:53Z","timestamp":1760135633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/3\/635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["biomedicines10030635"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10030635","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,9]]}}}